[{"arm_notes": "", "treatment_id": null, "treatment_name": "After laboratory result; intervention arm received ivermectin (at dose of 400 mcg/kg/day for 5 continuous days) plus standard of care which included favipiravir in moderately ill COVID-19 patients ;Controlled arm received standard of care alone which included favipiravir in moderately ill COVID-19 patients.;Active Comparator Drug;No Intervention Drug;Ivermectin Plus Favipiravir-Based Standard of Care versus Favipiravir-Based Standard of Care ;Controlled", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2473, "treatment_name": "Favipiravir+ivermectin", "treatment_type": "Antivirals+antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 504, "treatment_name": "Favipiravir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}]